Eastern Cooperative Oncology Group
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 2012-01-01
- Employees
- 51
- Market Cap
- -
- Website
- https://ecog-acrin.org
C-Met Inhibitor AMG 337, Oxaliplatin, Leucovorin Calcium, and Fluorouracil in Treating Patients With Advanced Stomach or Esophageal Cancer
Phase 1
Withdrawn
- Conditions
- Stage IIIA Esophageal CancerStage IIIA Gastric CancerStage IIIB Esophageal CancerStage IIIB Gastric CancerAdenocarcinoma of the EsophagusIntestinal Adenocarcinoma of the StomachAdenocarcinoma of the Gastroesophageal JunctionMixed Adenocarcinoma of the StomachStage IIIC Esophageal CancerStage IIIC Gastric Cancer
- Interventions
- Drug: c-Met inhibitor AMG 337Other: placeboOther: pharmacological studyOther: laboratory biomarker analysis
- First Posted Date
- 2015-01-26
- Last Posted Date
- 2023-05-25
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Registration Number
- NCT02344810
- Locations
- 🇺🇸
ECOG-ACRIN Cancer Research Group, Philadelphia, Pennsylvania, United States
A Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS)
Not Applicable
Active, not recruiting
- Conditions
- Estrogen Receptor-positive Breast CancerRecurrent Breast CancerMusculoskeletal ComplicationsProgesterone Receptor-positive Breast CancerStage IA Breast CancerStage IB Breast CancerStage II Breast CancerStage IIIA Breast CancerStage IIIB Breast CancerStage IIIC Breast Cancer
- Interventions
- First Posted Date
- 2013-04-05
- Last Posted Date
- 2025-05-31
- Lead Sponsor
- ECOG-ACRIN Cancer Research Group
- Target Recruit Count
- 1046
- Registration Number
- NCT01824836
- Locations
- 🇺🇸
Eastern Cooperative Oncology Group, Boston, Massachusetts, United States
🇺🇸Veterans Adminstration New Jersey Health Care System, East Orange, New Jersey, United States
PSA Antibody Levels in Samples From Patients With Prostate Cancer Treated on Protocol ECOG-E9802
Completed
- Conditions
- Prostate Cancer
- First Posted Date
- 2012-08-27
- Last Posted Date
- 2017-05-17
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Target Recruit Count
- 20
- Registration Number
- NCT01672905
Studying Genes in Samples From Younger Patients With Acute Lymphoblastic Leukemia
- Conditions
- Leukemia
- First Posted Date
- 2012-07-31
- Last Posted Date
- 2013-07-10
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Target Recruit Count
- 400
- Registration Number
- NCT01653613
Studying Biomarkers in Samples From Patients With Recurrent or Metastatic Head and Neck Cancer Treated on E1302 Trial
Completed
- Conditions
- Head and Neck Cancer
- First Posted Date
- 2012-06-14
- Last Posted Date
- 2017-05-17
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Target Recruit Count
- 183
- Registration Number
- NCT01619618
Biomarkers in Samples From Patients With B-Cell Acute Lymphoblastic Leukemia
Completed
- Conditions
- Leukemia
- First Posted Date
- 2012-01-06
- Last Posted Date
- 2017-05-17
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Target Recruit Count
- 186
- Registration Number
- NCT01505699
Tissue and Blood Biomarkers From Patients With Stage III or Stage IV Melanoma Treated With Ipilimumab With or Without Sargramostim
Completed
- Conditions
- Melanoma (Skin)
- First Posted Date
- 2011-12-09
- Last Posted Date
- 2017-05-17
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Target Recruit Count
- 270
- Registration Number
- NCT01489423
Biomarkers in Tissue Samples From Patients With Recurrent or Metastatic Head and Neck Cancer Treated on ECOG-E1395 and ECOG-E3301
Completed
- Conditions
- Head and Neck Cancer
- First Posted Date
- 2011-12-07
- Last Posted Date
- 2017-05-17
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Target Recruit Count
- 155
- Registration Number
- NCT01487733
Biomarkers in Patients With Metastatic or Recurrent Head and Neck Cancer Treated With Cisplatin and Cetuximab on ECOG-E5397
Completed
- Conditions
- Head and Neck Cancer
- First Posted Date
- 2011-11-06
- Last Posted Date
- 2017-05-17
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Target Recruit Count
- 42
- Registration Number
- NCT01466244
Biomarker Study of Chemotherapy Resistance and Outcomes in Samples From Older Patients With Acute Myeloid Leukemia
Completed
- Conditions
- Leukemia
- First Posted Date
- 2011-08-23
- Last Posted Date
- 2017-05-17
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Target Recruit Count
- 257
- Registration Number
- NCT01421875